retatrutide phase 2 nejm weight loss 48 weeks Trial of for Obesity obesity #retatrutide #weight #glp1 #nejm

This is also the phase where some people experience dysesthesia for the first time

Returning a product to the refrigerator does not extend the allowed time at room temperature

Most GLP-1 agonists do not require dose adjustment for mild to moderate renal impairment, though specific agents have varying recommendations for severe impairment

As anticipated, patient preference is towards GLP-1 RA profiles associated with less frequent dosing, with once-weekly preferred to once-daily, with the latter preferred over twice-daily [123,124,125]

Injection site rotation Retatrutide is administered subcutaneously, meaning into the fat layer just beneath the skin